Trial Profile
The Effect of Intrathecal Transplantation of Autologous Adipose Tissue Derived Mesenchymal Stem Cells in the Patients With Spinal Cord Injury, Phase I Clinical Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2015
Price :
$35
*
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Spinal cord injuries
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 06 Jun 2015 New trial record